These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21871076)

  • 21. Dietary management of X-linked adrenoleukodystrophy.
    Moser HW; Borel J
    Annu Rev Nutr; 1995; 15():379-97. PubMed ID: 8527226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lorenzo's oil--hope and disappointment.
    Rizzo WB
    N Engl J Med; 1993 Sep; 329(11):801-2. PubMed ID: 8043042
    [No Abstract]   [Full Text] [Related]  

  • 23. More on Lorenzo's oil.
    Odone A; Odone M
    N Engl J Med; 1994 Jun; 330(26):1904-5. PubMed ID: 8196741
    [No Abstract]   [Full Text] [Related]  

  • 24. A hierarchical Bayesian approach for combining pharmacokinetic/pharmacodynamic modeling and Phase IIa trial design in orphan drugs: Treating adrenoleukodystrophy with Lorenzo's oil.
    Basu C; Ahmed MA; Kartha RV; Brundage RC; Raymond GV; Cloyd JC; Carlin BP
    J Biopharm Stat; 2016; 26(6):1025-1039. PubMed ID: 27547896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of X-linked adrenoleukodystrophy with Lorenzo's oil.
    Moser HW
    J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):279-80. PubMed ID: 10449544
    [No Abstract]   [Full Text] [Related]  

  • 26. Lorenzo's oil: a reassessment.
    Poulos A; Robertson EF
    Med J Aust; 1994 Mar; 160(6):315-7. PubMed ID: 8133809
    [No Abstract]   [Full Text] [Related]  

  • 27. Lorenzo's oil therapy of adrenoleukodystrophy.
    DiGregorio VY; Schroeder DJ
    Ann Pharmacother; 1995 Mar; 29(3):312-3. PubMed ID: 7606079
    [No Abstract]   [Full Text] [Related]  

  • 28. Monitoring of very long-chain fatty acids levels in X-linked adrenoleukodystrophy, treated with haematopoietic stem cell transplantation and Lorenzo's Oil.
    Stradomska TJ; Drabko K; Moszczyńska E; Tylki-Szymańska A
    Folia Neuropathol; 2014; 52(2):159-63. PubMed ID: 25118901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Visual evoked potentials in adrenoleukodystrophy: a trial with glycerol trioleate and Lorenzo oil.
    Kaplan PW; Tusa RJ; Shankroff J; Heller J; Moser HW
    Ann Neurol; 1993 Aug; 34(2):169-74. PubMed ID: 8338341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adrenoleukodystrophy and the mitochondrial connection: clues for supplementing Lorenzo's oil.
    Moraes CT
    Brain; 2013 Aug; 136(Pt 8):2339-41. PubMed ID: 23842565
    [No Abstract]   [Full Text] [Related]  

  • 31. Komrower Lecture. Adrenoleukodystrophy: natural history, treatment and outcome.
    Moser HW
    J Inherit Metab Dis; 1995; 18(4):435-47. PubMed ID: 7494402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lorenzo's oil may help to prevent ALD symptoms.
    Senior K
    Lancet Neurol; 2002 Dec; 1(8):468. PubMed ID: 12849323
    [No Abstract]   [Full Text] [Related]  

  • 33. [Lorenzo's oil. A realistic presentation of two parents' fight against adrenoleukodystrophy].
    Söderfeldt B
    Lakartidningen; 1993 May; 90(20):1969-72. PubMed ID: 8502039
    [No Abstract]   [Full Text] [Related]  

  • 34. A mixture of oleic, erucic and conjugated linoleic acids modulates cerebrospinal fluid inflammatory markers and improve somatosensorial evoked potential in X-linked adrenoleukodystrophy female carriers.
    Cappa M; Bizzarri C; Petroni A; Carta G; Cordeddu L; Valeriani M; Vollono C; De Pasquale L; Blasevich M; Banni S
    J Inherit Metab Dis; 2012 Sep; 35(5):899-907. PubMed ID: 22189598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Backache as the initial symptom of adrenomyeloneuropathy].
    Benito-León J; Zamorano T; Martín-Peña G; Tapia MA; Alvarez-Linera J
    Rev Neurol; 2000 Dec 16-31; 31(12):1167-70. PubMed ID: 11205553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Adrenoleukodystrophy: Lorenzo's Oil].
    Yamawaki T
    Brain Nerve; 2022 Dec; 74(12):1354-1357. PubMed ID: 36503132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapy of X-linked adrenoleukodystrophy.
    Semmler A; Köhler W; Jung HH; Weller M; Linnebank M
    Expert Rev Neurother; 2008 Sep; 8(9):1367-79. PubMed ID: 18759549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Endocrine disease in adrenoleukodystrophy].
    Girard S; Bruckert E; Turpin G
    Ann Med Interne (Paris); 2001 Feb; 152(1):15-26. PubMed ID: 11240421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced lymphocyte proliferation in patients with adrenoleukodystrophy treated with erucic acid (22:1)-rich triglycerides.
    Pour RB; Stöckler-Ipsiroglu S; Hunneman DH; Gahr M; Korenke GC; Pabst W; Hanefeld F; Peters A
    J Inherit Metab Dis; 2000 Mar; 23(2):113-9. PubMed ID: 10801052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma and red blood cell fatty acids in peroxisomal disorders.
    Moser AB; Jones DS; Raymond GV; Moser HW
    Neurochem Res; 1999 Feb; 24(2):187-97. PubMed ID: 9972864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.